CAMBRIDGE, Britain (AP) _ Astrazeneca PLC (AZN) on Thursday reported third-quarter net income of $1.64 billion, after reporting a loss in the same period a year earlier.

On a per-share basis, the Cambridge, Britain-based company said it had profit of 53 cents. Earnings, adjusted for non-recurring costs, came to 84 cents per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 77 cents per share.

The pharmaceutical posted revenue of $10.98 billion in the period.

Astrazeneca shares have climbed almost 5% since the beginning of the year. The stock has decreased almost 3% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AZN at https://www.zacks.com/ap/AZN

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News